RUSSELL MCCAIG: Open Payments
NPI 1013983949 · EL DORADO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 33 payments from 11 companies in 2025. Trend: 2023 $2,424 · 2024 $2,043 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $145 |
| AstraZeneca Pharmaceuticals LP | 5 | $136 |
| Amgen Inc. | 6 | $99 |
| ABBVIE INC. | 3 | $44 |
| Astellas Pharma US Inc | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Dexcom, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $17 |
Products named: BREZTRI, Wegovy, EVENITY, Ozempic, OTEZLA, Rybelsus, Veozah, CAPLYTA.
Industry payments across KS — which companies pay providers there.
